There was no statistically significant treatment difference in rates of recurrent severe exacerbations ( treatment ratio @ -LSB- @ % CI : @ , @ -RSB- ) and moderate/severe exacerbations ( @ -LSB- @ , @ -RSB- ) between FP/SAL and SAL in the intent-to-treat population .